businessmayor

market

Cashing out in biotech in 2022: On-target predictions for AbbVie, Vertex and Genmab

Panuwat Dangsungnoen/iStock via Getty Images Seeking Contributors urged investors to buy AbbVie (NYSE:ABBV), Vertex Pharma (NASDAQ:VRTX), Genmab (GMAB) and a range of other biotechs in 2022 long before those stocks outperformed − sometimes even as the consensus view on Wall...

Media

A #MeToo reckoning comes to New York courts

E Jean Carroll had more reasons than usual to anticipate this year’s Thanksgiving weekend. Under a landmark New York law that came into effect on the US holiday, the 79-year old journalist and author was finally able to sue Donald...

1 7,070 7,071 7,072 7,085
Page 7071 of 7085

This website uses cookies. By continuing to use this site, you accept our use of cookies.